Daily ShareChat: Abano Healthcare
By Jenny Ruth
Abano Healthcare's profit guidance has led him to cut his forecasts, says John Cairns, an analyst at Forsyth Barr.
The company says earnings before interest, tax, depreciation and amortisation (EBITDA) for the year ending May 31 are likely to be between $17 million and $18 million including an equity-accounted loss from Bay International.
Cairns says he has downgraded his EBITDA forecast, excluding Bay International, by 2% to $20.1 million and has lowered his valuation of the stock from $6.58 to $6.29.
"Dental revenue and EBITDA performance has been impacted by delays in the settlement of acquisitions which are now expected to take place over the next three months," Cairns says.
"As a consequence, the acquisition cost will be incurred in full-year 2011 without the benefit of a full year contribution of earnings," he says.
The company's decision to maintain its full-year 2011 dividend at 21 cents per share is a sign of the company's confidence in the underlying performance of its business units, he says.
The earnings potential of Bay International, to which he attributes negligible value currently, will only become apparent over the next three to four years, by which time the store network will be of sufficient scale to absorb start-up costs, Cairns says.
Recommendation: Accumulate (from Buy).
DISCLAIMER: To the extent that any of the content above constitutes advice, it is general advice that has been prepared without reference to investor’s objectives, financial situation or needs. Before acting on any advice, investors should consider the appropriateness of the advice and IRG recommend that investors should obtain appropriate financial, legal and taxation advice before making any financial investment decision. The report is based on information compiled from public information and private research. IRG have completed the report on a best endeavours basis and do not accept any liability of loss or damage. IRG suggest that clients use this as part of a decision making process and check key data before making any investment decisions.
Employees may have an interest in the securities discussed in this report.
Comments from our readers
No comments yet
Add your comment:
Hutson fails to respond to Abano buyout offer, takeover 'rife with insider elements'
Abano steps up pressure on bidders over audiology unit price
Abano shareholders clamour for discounted stock in share purchase plan
Hutson quits Abano board after urging from other directors
Abano board questions Hutson's conflict of interest in takeover bid
Abano continues to resist takeovers, rejects approach from Archer, Hutson
Abano seeks $18.5 mln in share purchase plan
Abano shares climb to 4-month high amid prospect of takeover bid
Abano faces takeover bid after rejecting unsolicited offer
Abano reports 75 percent NPAT uplift to $2.8 mln on $207 mln turnover